abstract |
(57) [Summary]nThe invention relates to the use of mono- and amide derivatives of bicarboxylic acids with amino alcohols or amino ethers, which can selectively act on said receptors, in the manufacture of a medicament for the treatment of diseases associated with modulation of cannabinoid peripheral receptors. |